Profile - To The Moon

Hopetan

Posts · 5Posts · 5
Following · 0Following · 0
Followers · 0Followers · 0

- HopetanHopetan
  ·2021-12-25
  May this Xmas season brings everyone joy &blessings!!
  S&P 5,000? Here's What Analysts And Investors Expect From The Stock Market In 2022
  As 2021 winds to a close, investors and analysts are already shifting their focus to 2022. This year
  S&P 5,000? Here's What Analysts And Investors Expect From The Stock Market In 2022
  458 Comment
  3
  Share
  Report
- HopetanHopetan
  ·2021-12-25
  Merry Xmas everyone!! I just hope Nio goes back up to the $60s and beyond!! Please donot delist
  A Christmas Wish List For EV Makers
  Wall Street is unanimous about the massive electric vehicle market opportunity set to unfold in the coming years. Against this backdrop, an analyst at Wedbush pondered what could be on Christmas wish lists for the EV makers.Christmas Wish List:The EV sectors would be hoping for two things heading into Christmas and the end of the year, Ives said.Moderation in the chip shortage that severely constrained production.Hope the EV demand inflection predicted for 2022 materializes.$5T Market Opportunit
  A Christmas Wish List For EV Makers
  329 Comment
  1
  Share
  Report
- HopetanHopetan
  ·2021-12-25
  Merry Xmas all!! :))
  Colin Kaepernick SPAC deal with minority lender is said to collapse
  Colin Kaepernick-backed SPAC Mission Advancement Corp.'sdeal to buy a lender that focused on minority borrowers is to have collapsed.The SPAC's deal to acquire The Change Co. is said to have ended over the former NFL quarterback and social activist's reluctance to appear on TV to promote the deal including appearing on "Good Morning America," according to a WSJ report. Kaepernick declined to be involved in interviews surrounding the transaction.A spokesman for Kaepernick’s Mission Advancement to
  Colin Kaepernick SPAC deal with minority lender is said to collapse
  515 Comment
  1
  Share
  Report
- HopetanHopetan
  ·2021-12-25
  Merry Xmas everyone!!
  Electric boat developer Forza X1 files for a $29 million IPO
  Forza X1, a fully electric boat developer being spun out of Twin Vee PowerCats, filed on Thursday wi
  Electric boat developer Forza X1 files for a $29 million IPO
  337 Comment
  Like
  Share
  Report
- HopetanHopetan
  ·2021-12-25
  No I won’t buy JJ
  3 Best Buffett Stocks to Buy for the Long Haul
  Each of these three big pharma stocks are featured in Berkshire Hathaway's massive portfolio.
  3 Best Buffett Stocks to Buy for the Long Haul
  312 Comment
  1
  Share
  Report

Most Discussed

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"isCurrentUser":false,"userPageInfo":{"id":"3564731975036846","uuid":"3564731975036846","gmtCreate":1601645092859,"gmtModify":1601999332933,"name":"Hopetan","pinyin":"hopetan","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/8ae642a98538e037ac75b97b73225633","hat":"https://static.tigerbbs.com/b073a07f77dbe6b3bec6b12311fde6bd","hatId":"ca_profile_frame_Mpy1eK","hatName":"","vip":1,"status":2,"fanSize":2,"headSize":10,"tweetSize":5,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-3","templateUuid":"1026c425416b44e0aac28c11a0848493","name":" Tiger Idol","description":"Join the tiger community for 1500 days","bigImgUrl":"https://static.tigerbbs.com/8b40ae7da5bf081a1c84df14bf9e6367","smallImgUrl":"https://static.tigerbbs.com/f160eceddd7c284a8e1136557615cfad","grayImgUrl":"https://static.tigerbbs.com/11792805c468334a9b31c39f95a41c6a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.11.11","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"44212b71d0be4ec88898348dbe882e03-3","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"President Tiger","description":"The transaction amount of the securities account reaches $1,000,000","bigImgUrl":"https://static.tigerbbs.com/fbeac6bb240db7da8b972e5183d050ba","smallImgUrl":"https://static.tigerbbs.com/436cdf80292b99f0a992e78750ac4e3a","grayImgUrl":"https://static.tigerbbs.com/506a259a7b456f037592c3b23c779599","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"93.98%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"972123088c9646f7b6091ae0662215be-3","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Legendary Trader","description":"Total number of securities or futures transactions reached 300","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"93.20%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":4,"crmLevelSwitch":1,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":9009938835,"gmtCreate":1640413391141,"gmtModify":1676533520268,"author":{"id":"3564731975036846","authorId":"3564731975036846","name":"Hopetan","avatar":"https://static.tigerbbs.com/8ae642a98538e037ac75b97b73225633","crmLevel":4,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3564731975036846","authorIdStr":"3564731975036846"},"themes":[],"htmlText":"May this Xmas season brings everyone joy &amp;blessings!!&nbsp;","listText":"May this Xmas season brings everyone joy &amp;blessings!!&nbsp;","text":"May this Xmas season brings everyone joy &blessings!!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9009938835","repostId":"1132821017","repostType":4,"repost":{"id":"1132821017","pubTimestamp":1640393119,"share":"https://ttm.financial/m/news/1132821017?lang=&edition=fundamental","pubTime":"2021-12-25 08:45","market":"us","language":"en","title":"S&P 5,000? Here's What Analysts And Investors Expect From The Stock Market In 2022","url":"https://stock-news.laohu8.com/highlight/detail?id=1132821017","media":"Benzinga","summary":"As 2021 winds to a close, investors and analysts are already shifting their focus to 2022. This year","content":"<p>As 2021 winds to a close, investors and analysts are already shifting their focus to 2022. This year marked the third consecutive year of at least 16% returns for the S&amp;P 500, leaving investors to wonder just how much more upside they can expect from the&nbsp;<b>SPDR S&amp;P 500 ETF Trust</b>(NYSE:SPY) in 2022.</p>\n<p><b>Landmark Target:</b>&nbsp;LPL Financial Chief Market Strategist Ryan Detrick recently said he’s optimistic about the potential for the S&amp;P 500 to hit the landmark 5,000 level in 2022.</p>\n<p>“We believe the S&amp;P 500 could be fairly valued at 5,000–5,100 at the end of 2022, based on an EPS estimate of $235 for 2023 and an index P/E between 21 and 21.5,” Detrick said in LPL’s 2022outlook report.</p>\n<p>Detrick said hitting and exceeding that price target range next year will hinge largely on corporate earnings. If interest rates stay lower for longer than the market expects, a strong economy and positive investor sentiment could support additional earnings upside and even further earnings multiple expansion, he said. However, if inflation, wage growth and rising interest rates pressure margins in 2022, Detrick said any S&amp;P 500 earnings growth at all may be hard to come by in 2022.</p>\n<p>For the S&amp;P 500 to hit 5,000, it will need to gain only about 6.2% from current levels, a relatively modest annual return for the index on a historical basis.</p>\n<p><b>Opportunities Ahead:</b>In his Daily Market Notes, Navellier CIO Louis Navellier recently said investors should continue to have opportunities in the market in 2022, but stock selection could become more important.</p>\n<p>“Although year-over-year earnings comparisons will become more difficult in 2022, a narrower market is good news for growth stocks and dividend growth stocks and bad news for the ‘index fund’ crowd, since growth stocks and dividend growth stocks have traditionally prospered in a narrowing, more selective, stock market environment like this,” Navellier said.</p>\n<p>He noted that Democrats are also likely to lose control of both the House of Representatives and the Senate in the 2022 midterm elections, and Wall Street has historically favored a divided government.</p>\n<p><b>Investor Survey Results:</b>&nbsp;DataTrek Research’s annual investor survey suggests investors are executing modest, positive returns from the S&amp;P 500 in 2022. In fact, 81% of investors surveyed are anticipating S&amp;P 500 returns in 2022 will be between 0% and 15% for the year, with 42% of respondents anticipating returns in the 5% to 10% range.</p>\n<p>“No wonder December is proving difficult, for if an investor thinks next year’s gains will be limited then selling ahead of a so-so year is a solid strategy,” DataTrek co-founder Nicholas Colas said.</p>\n<p>Colas recently pointed out that the aggregate 12-month price target for the S&amp;P 500 based on analysts’ single-stock price targets is 5,225.</p>\n<p><b>Benzinga’s Take:</b>&nbsp;It’s extremely difficult to predict what the stock market will do in any given year, but the S&amp;P 500’s long-term track record has been remarkably consistent throughout history. Since 1925, the rolling 35-year annual returns for the S&amp;P 500 have&nbsp;always stayed&nbsp;between around 8% and around 15%.</p>","source":"lsy1606299360108","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>S&P 5,000? Here's What Analysts And Investors Expect From The Stock Market In 2022</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nS&P 5,000? Here's What Analysts And Investors Expect From The Stock Market In 2022\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-25 08:45 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/analyst-ratings/analyst-color/21/12/24757408/s-p-5-000-heres-what-analysts-and-investors-expect-from-the-stock-market-in-2022><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>As 2021 winds to a close, investors and analysts are already shifting their focus to 2022. This year marked the third consecutive year of at least 16% returns for the S&P 500, leaving investors to ...</p>\n\n<a href=\"https://www.benzinga.com/analyst-ratings/analyst-color/21/12/24757408/s-p-5-000-heres-what-analysts-and-investors-expect-from-the-stock-market-in-2022\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index"},"source_url":"https://www.benzinga.com/analyst-ratings/analyst-color/21/12/24757408/s-p-5-000-heres-what-analysts-and-investors-expect-from-the-stock-market-in-2022","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1132821017","content_text":"As 2021 winds to a close, investors and analysts are already shifting their focus to 2022. This year marked the third consecutive year of at least 16% returns for the S&P 500, leaving investors to wonder just how much more upside they can expect from the SPDR S&P 500 ETF Trust(NYSE:SPY) in 2022.\nLandmark Target: LPL Financial Chief Market Strategist Ryan Detrick recently said he’s optimistic about the potential for the S&P 500 to hit the landmark 5,000 level in 2022.\n“We believe the S&P 500 could be fairly valued at 5,000–5,100 at the end of 2022, based on an EPS estimate of $235 for 2023 and an index P/E between 21 and 21.5,” Detrick said in LPL’s 2022outlook report.\nDetrick said hitting and exceeding that price target range next year will hinge largely on corporate earnings. If interest rates stay lower for longer than the market expects, a strong economy and positive investor sentiment could support additional earnings upside and even further earnings multiple expansion, he said. However, if inflation, wage growth and rising interest rates pressure margins in 2022, Detrick said any S&P 500 earnings growth at all may be hard to come by in 2022.\nFor the S&P 500 to hit 5,000, it will need to gain only about 6.2% from current levels, a relatively modest annual return for the index on a historical basis.\nOpportunities Ahead:In his Daily Market Notes, Navellier CIO Louis Navellier recently said investors should continue to have opportunities in the market in 2022, but stock selection could become more important.\n“Although year-over-year earnings comparisons will become more difficult in 2022, a narrower market is good news for growth stocks and dividend growth stocks and bad news for the ‘index fund’ crowd, since growth stocks and dividend growth stocks have traditionally prospered in a narrowing, more selective, stock market environment like this,” Navellier said.\nHe noted that Democrats are also likely to lose control of both the House of Representatives and the Senate in the 2022 midterm elections, and Wall Street has historically favored a divided government.\nInvestor Survey Results: DataTrek Research’s annual investor survey suggests investors are executing modest, positive returns from the S&P 500 in 2022. In fact, 81% of investors surveyed are anticipating S&P 500 returns in 2022 will be between 0% and 15% for the year, with 42% of respondents anticipating returns in the 5% to 10% range.\n“No wonder December is proving difficult, for if an investor thinks next year’s gains will be limited then selling ahead of a so-so year is a solid strategy,” DataTrek co-founder Nicholas Colas said.\nColas recently pointed out that the aggregate 12-month price target for the S&P 500 based on analysts’ single-stock price targets is 5,225.\nBenzinga’s Take: It’s extremely difficult to predict what the stock market will do in any given year, but the S&P 500’s long-term track record has been remarkably consistent throughout history. Since 1925, the rolling 35-year annual returns for the S&P 500 have always stayed between around 8% and around 15%.","news_type":1},"isVote":1,"tweetType":1,"viewCount":458,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9009938130,"gmtCreate":1640413336165,"gmtModify":1676533520267,"author":{"id":"3564731975036846","authorId":"3564731975036846","name":"Hopetan","avatar":"https://static.tigerbbs.com/8ae642a98538e037ac75b97b73225633","crmLevel":4,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3564731975036846","authorIdStr":"3564731975036846"},"themes":[],"htmlText":"Merry Xmas everyone!! I just hope Nio goes back up to the $60s and beyond!! Please donot delist","listText":"Merry Xmas everyone!! I just hope Nio goes back up to the $60s and beyond!! Please donot delist","text":"Merry Xmas everyone!! I just hope Nio goes back up to the $60s and beyond!! Please donot delist","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9009938130","repostId":"1173048178","repostType":4,"repost":{"id":"1173048178","pubTimestamp":1640393368,"share":"https://ttm.financial/m/news/1173048178?lang=&edition=fundamental","pubTime":"2021-12-25 08:49","market":"us","language":"en","title":"A Christmas Wish List For EV Makers","url":"https://stock-news.laohu8.com/highlight/detail?id=1173048178","media":"Benzinga","summary":"Wall Street is unanimous about the massive electric vehicle market opportunity set to unfold in the coming years. Against this backdrop, an analyst at Wedbush pondered what could be on Christmas wish lists for the EV makers.Christmas Wish List:The EV sectors would be hoping for two things heading into Christmas and the end of the year, Ives said.Moderation in the chip shortage that severely constrained production.Hope the EV demand inflection predicted for 2022 materializes.$5T Market Opportunit","content":"<p>Wall Street is unanimous about the massive electric vehicle&nbsp;market opportunity set to unfold in the coming years. Against this backdrop, an analyst at Wedbush pondered what could be on&nbsp;Christmas wish lists&nbsp;for the EV makers.</p>\n<p><b>Christmas Wish List:</b>The EV sectors would be hoping for two things heading into Christmas and the end of the year, Ives said.</p>\n<ul>\n <li>Moderation in the chip shortage that severely constrained production.</li>\n <li>Hope the EV demand inflection predicted for 2022 materializes.</li>\n</ul>\n<p><b>$5T Market Opportunity Over Next Decade:</b>&nbsp;The EV revolution&nbsp;expected to materialize in 2022 and beyond will translate to a $5 trillion market opportunity over the next decade,&nbsp;Ives said in the note.&nbsp;<b>Tesla&nbsp;Inc</b>(NASDAQ:TSLA) will be the major beneficiary of the inflection, the analyst said.</p>\n<p>Others such as&nbsp;traditional automakers&nbsp;<b>General Motors Company</b>(NYSE:GM),&nbsp;<b>Volkswagen AG</b>(OTC:VWAGY) and&nbsp;<b>Ford Motor Company</b>(NYSE:F), as well as EV-focused vendors<b>Canoo Inc</b>(NASDAQ:GOEV),&nbsp;<b>Lucid Group&nbsp;Inc</b>(NASDAQ:LCID),&nbsp;<b>Fisker&nbsp;Inc</b>(NYSE:FSR) and&nbsp;<b>Rivian Automotive&nbsp;Inc</b>(NASDAQ:RIVN) also stand to capitalize, he added.</p>\n<p>Europe and China have seen a clear acceleration in EV adoption.&nbsp;The U.S., with just 2% penetration, lags behind, the analyst noted.</p>\n<p>EV supply chain plays such as&nbsp;<b>Li-Cycle Holdings Corp</b>(NYSE:LICY),&nbsp;<b>ChargePoint Holdings&nbsp;Inc</b>(NYSE:CHPT),&nbsp;<b>Evgo&nbsp;Inc</b>(NASDAQ:EVGO),&nbsp;<b>Electric Last Mile Solutions&nbsp;Inc</b>(NASDAQ:ELMS),&nbsp;<b>Xos&nbsp;Inc</b>(NASDAQ:XOS) and&nbsp;<b>Hyzon Motors Inc</b>(NASDAQ:HYZN), among others are well-positioned to benefit, Ives said.</p>\n<p>On the software front,&nbsp;connected data&nbsp;plays such as&nbsp;<b>Wejo Group Ltd</b>(NASDAQ:WEJO) are likely to benefit from the next generation of EVs and adoption taking hold over the next 12 to 18 months, he added.</p>\n<p><b>EV Valuations Reflecting Future Growth:</b>&nbsp;EV valuations continue to soar, leading many to wonder whether this is a bubble or the first stage of a decade-long EV metamorphosis, Ives said.</p>\n<p>\"The EV stocks are reflecting future parabolic growth and margin potential over the coming years, with now the execution/capacity story taking hold into 2022,\" the analyst wrote in the note.</p>","source":"lsy1606299360108","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>A Christmas Wish List For EV Makers</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nA Christmas Wish List For EV Makers\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-25 08:49 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/analyst-ratings/analyst-color/21/12/24757706/a-christmas-wish-list-for-ev-makers><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Wall Street is unanimous about the massive electric vehicle market opportunity set to unfold in the coming years. Against this backdrop, an analyst at Wedbush pondered what could be on Christmas wish ...</p>\n\n<a href=\"https://www.benzinga.com/analyst-ratings/analyst-color/21/12/24757706/a-christmas-wish-list-for-ev-makers\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"F":"福特汽车","TSLA":"特斯拉"},"source_url":"https://www.benzinga.com/analyst-ratings/analyst-color/21/12/24757706/a-christmas-wish-list-for-ev-makers","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1173048178","content_text":"Wall Street is unanimous about the massive electric vehicle market opportunity set to unfold in the coming years. Against this backdrop, an analyst at Wedbush pondered what could be on Christmas wish lists for the EV makers.\nChristmas Wish List:The EV sectors would be hoping for two things heading into Christmas and the end of the year, Ives said.\n\nModeration in the chip shortage that severely constrained production.\nHope the EV demand inflection predicted for 2022 materializes.\n\n$5T Market Opportunity Over Next Decade: The EV revolution expected to materialize in 2022 and beyond will translate to a $5 trillion market opportunity over the next decade, Ives said in the note. Tesla Inc(NASDAQ:TSLA) will be the major beneficiary of the inflection, the analyst said.\nOthers such as traditional automakers General Motors Company(NYSE:GM), Volkswagen AG(OTC:VWAGY) and Ford Motor Company(NYSE:F), as well as EV-focused vendorsCanoo Inc(NASDAQ:GOEV), Lucid Group Inc(NASDAQ:LCID), Fisker Inc(NYSE:FSR) and Rivian Automotive Inc(NASDAQ:RIVN) also stand to capitalize, he added.\nEurope and China have seen a clear acceleration in EV adoption. The U.S., with just 2% penetration, lags behind, the analyst noted.\nEV supply chain plays such as Li-Cycle Holdings Corp(NYSE:LICY), ChargePoint Holdings Inc(NYSE:CHPT), Evgo Inc(NASDAQ:EVGO), Electric Last Mile Solutions Inc(NASDAQ:ELMS), Xos Inc(NASDAQ:XOS) and Hyzon Motors Inc(NASDAQ:HYZN), among others are well-positioned to benefit, Ives said.\nOn the software front, connected data plays such as Wejo Group Ltd(NASDAQ:WEJO) are likely to benefit from the next generation of EVs and adoption taking hold over the next 12 to 18 months, he added.\nEV Valuations Reflecting Future Growth: EV valuations continue to soar, leading many to wonder whether this is a bubble or the first stage of a decade-long EV metamorphosis, Ives said.\n\"The EV stocks are reflecting future parabolic growth and margin potential over the coming years, with now the execution/capacity story taking hold into 2022,\" the analyst wrote in the note.","news_type":1},"isVote":1,"tweetType":1,"viewCount":329,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9009938395,"gmtCreate":1640413279066,"gmtModify":1676533520259,"author":{"id":"3564731975036846","authorId":"3564731975036846","name":"Hopetan","avatar":"https://static.tigerbbs.com/8ae642a98538e037ac75b97b73225633","crmLevel":4,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3564731975036846","authorIdStr":"3564731975036846"},"themes":[],"htmlText":"Merry Xmas all!! :))&nbsp;","listText":"Merry Xmas all!! :))&nbsp;","text":"Merry Xmas all!! :))","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9009938395","repostId":"1127627237","repostType":4,"repost":{"id":"1127627237","pubTimestamp":1640394374,"share":"https://ttm.financial/m/news/1127627237?lang=&edition=fundamental","pubTime":"2021-12-25 09:06","market":"us","language":"en","title":"Colin Kaepernick SPAC deal with minority lender is said to collapse","url":"https://stock-news.laohu8.com/highlight/detail?id=1127627237","media":"Seeking Alpha","summary":"Colin Kaepernick-backed SPAC Mission Advancement Corp.'sdeal to buy a lender that focused on minority borrowers is to have collapsed.The SPAC's deal to acquire The Change Co. is said to have ended over the former NFL quarterback and social activist's reluctance to appear on TV to promote the deal including appearing on \"Good Morning America,\" according to a WSJ report. Kaepernick declined to be involved in interviews surrounding the transaction.A spokesman for Kaepernick’s Mission Advancement to","content":"<ul>\n <li>Colin Kaepernick-backed SPAC Mission Advancement Corp.'s(NYSE:MACC)deal to buy a lender that focused on minority borrowers is to have&nbsp;collapsed.</li>\n <li>The SPAC's deal to acquire The Change Co. is said to have ended over the former NFL quarterback and social activist's reluctance to appear on TV to promote the deal including appearing on \"Good Morning America,\" according to a&nbsp;WSJ&nbsp;report. Kaepernick declined to be involved in interviews surrounding the transaction.</li>\n <li>A spokesman for Kaepernick’s Mission Advancement told the paper said the SPAC will continue to look for a merger partner in 2022.</li>\n <li>Mission’s IPO in early March sold 30M investment units at $10 a&nbsp;piece&nbsp;to raise $300M.</li>\n <li>Kaepernick, a former NFL quarterback, serves as MACCU’s co-chairman. He came to wide attention in 2016 while playing for the San Francisco 49ers by kneeling rather than standing during the playing of the U.S. national anthem at games’ beginnings. Kaepernick, who is biracial, was protesting U.S. racial issues.</li>\n <li>The protest expanded over time, with other NFL players and pro athletes in different sports kneeling when the U.S. national anthem played. That’s made Kaepernick a controversial figure, loved by some and hated by others.</li>\n <li>Kaepernick is not the only professional athlete or celebrity to be involved in a SPAC. Back in March, Patrick Mahomes, Justin Verlander backed a SPAC called&nbsp;Disruptive Acquisition Corp. I(NASDAQ:DISAU).</li>\n</ul>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Colin Kaepernick SPAC deal with minority lender is said to collapse</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nColin Kaepernick SPAC deal with minority lender is said to collapse\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-25 09:06 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3783327-colin-kaepernick-spac-deal-with-minority-lender-is-said-to-collapse><strong>Seeking Alpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Colin Kaepernick-backed SPAC Mission Advancement Corp.'s(NYSE:MACC)deal to buy a lender that focused on minority borrowers is to have collapsed.\nThe SPAC's deal to acquire The Change Co. is said to ...</p>\n\n<a href=\"https://seekingalpha.com/news/3783327-colin-kaepernick-spac-deal-with-minority-lender-is-said-to-collapse\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://seekingalpha.com/news/3783327-colin-kaepernick-spac-deal-with-minority-lender-is-said-to-collapse","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1127627237","content_text":"Colin Kaepernick-backed SPAC Mission Advancement Corp.'s(NYSE:MACC)deal to buy a lender that focused on minority borrowers is to have collapsed.\nThe SPAC's deal to acquire The Change Co. is said to have ended over the former NFL quarterback and social activist's reluctance to appear on TV to promote the deal including appearing on \"Good Morning America,\" according to a WSJ report. Kaepernick declined to be involved in interviews surrounding the transaction.\nA spokesman for Kaepernick’s Mission Advancement told the paper said the SPAC will continue to look for a merger partner in 2022.\nMission’s IPO in early March sold 30M investment units at $10 a piece to raise $300M.\nKaepernick, a former NFL quarterback, serves as MACCU’s co-chairman. He came to wide attention in 2016 while playing for the San Francisco 49ers by kneeling rather than standing during the playing of the U.S. national anthem at games’ beginnings. Kaepernick, who is biracial, was protesting U.S. racial issues.\nThe protest expanded over time, with other NFL players and pro athletes in different sports kneeling when the U.S. national anthem played. That’s made Kaepernick a controversial figure, loved by some and hated by others.\nKaepernick is not the only professional athlete or celebrity to be involved in a SPAC. Back in March, Patrick Mahomes, Justin Verlander backed a SPAC called Disruptive Acquisition Corp. I(NASDAQ:DISAU).","news_type":1},"isVote":1,"tweetType":1,"viewCount":515,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9009938977,"gmtCreate":1640413259584,"gmtModify":1676533520267,"author":{"id":"3564731975036846","authorId":"3564731975036846","name":"Hopetan","avatar":"https://static.tigerbbs.com/8ae642a98538e037ac75b97b73225633","crmLevel":4,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3564731975036846","authorIdStr":"3564731975036846"},"themes":[],"htmlText":"Merry Xmas everyone!!&nbsp;","listText":"Merry Xmas everyone!!&nbsp;","text":"Merry Xmas everyone!!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9009938977","repostId":"1159652805","repostType":4,"repost":{"id":"1159652805","pubTimestamp":1640397611,"share":"https://ttm.financial/m/news/1159652805?lang=&edition=fundamental","pubTime":"2021-12-25 10:00","market":"us","language":"en","title":"Electric boat developer Forza X1 files for a $29 million IPO","url":"https://stock-news.laohu8.com/highlight/detail?id=1159652805","media":"Renaissance Capital","summary":"Forza X1, a fully electric boat developer being spun out of Twin Vee PowerCats, filed on Thursday wi","content":"<p>Forza X1, a fully electric boat developer being spun out of Twin Vee PowerCats, filed on Thursday with the SEC to raise up to $29 million in an initial public offering.</p>\n<p>The company states that it&nbsp;aims to be among the first to develop and manufacture fully electric, affordable boats with mass appeal. Forza X1 is focused on the creation and implementation of marine electric vehicle (\"EV\") technology to control and power its electric boats utilizing a proprietary outboard electric motor. It believes to be one the first companies to design a fully integrated electric boat including the hull, outboard motor and control system for mass production. To date, Forza has designed and manufactured only prototypes of its electric sport boat, has not yet commercialized its boats, and has not sold any boats.</p>\n<p>The Ft. Pierce, FL-based company was founded in 2009 and plans to list on the Nasdaq under the symbol&nbsp;FRZA. ThinkEquity is the sole bookrunner on the deal. No pricing terms were disclosed.</p>","source":"lsy1603787993745","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Electric boat developer Forza X1 files for a $29 million IPO</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nElectric boat developer Forza X1 files for a $29 million IPO\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-25 10:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.renaissancecapital.com/IPO-Center/News/89801/Electric-boat-developer-Forza-X1-files-for-a-$29-million-IPO><strong>Renaissance Capital</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Forza X1, a fully electric boat developer being spun out of Twin Vee PowerCats, filed on Thursday with the SEC to raise up to $29 million in an initial public offering.\nThe company states that it aims...</p>\n\n<a href=\"https://www.renaissancecapital.com/IPO-Center/News/89801/Electric-boat-developer-Forza-X1-files-for-a-$29-million-IPO\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.renaissancecapital.com/IPO-Center/News/89801/Electric-boat-developer-Forza-X1-files-for-a-$29-million-IPO","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1159652805","content_text":"Forza X1, a fully electric boat developer being spun out of Twin Vee PowerCats, filed on Thursday with the SEC to raise up to $29 million in an initial public offering.\nThe company states that it aims to be among the first to develop and manufacture fully electric, affordable boats with mass appeal. Forza X1 is focused on the creation and implementation of marine electric vehicle (\"EV\") technology to control and power its electric boats utilizing a proprietary outboard electric motor. It believes to be one the first companies to design a fully integrated electric boat including the hull, outboard motor and control system for mass production. To date, Forza has designed and manufactured only prototypes of its electric sport boat, has not yet commercialized its boats, and has not sold any boats.\nThe Ft. Pierce, FL-based company was founded in 2009 and plans to list on the Nasdaq under the symbol FRZA. ThinkEquity is the sole bookrunner on the deal. No pricing terms were disclosed.","news_type":1},"isVote":1,"tweetType":1,"viewCount":337,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9009931424,"gmtCreate":1640413175889,"gmtModify":1676533520259,"author":{"id":"3564731975036846","authorId":"3564731975036846","name":"Hopetan","avatar":"https://static.tigerbbs.com/8ae642a98538e037ac75b97b73225633","crmLevel":4,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3564731975036846","authorIdStr":"3564731975036846"},"themes":[],"htmlText":"No I won’t buy JJ","listText":"No I won’t buy JJ","text":"No I won’t buy JJ","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9009931424","repostId":"2193917872","repostType":4,"repost":{"id":"2193917872","pubTimestamp":1640398248,"share":"https://ttm.financial/m/news/2193917872?lang=&edition=fundamental","pubTime":"2021-12-25 10:10","market":"us","language":"en","title":"3 Best Buffett Stocks to Buy for the Long Haul","url":"https://stock-news.laohu8.com/highlight/detail?id=2193917872","media":"Motley Fool","summary":"Each of these three big pharma stocks are featured in Berkshire Hathaway's massive portfolio.","content":"<p>Since Warren Buffett took full control of <b>Berkshire Hathaway</b> in 1965, it became a diversified holding company with investments in publicly traded companies totaling nearly $345 billion at the time of writing.</p>\n<p>The Oracle of Omaha's reputation of buying the highest quality businesses means that many individual investors could also benefit from adding these stocks to their portfolios. Here are three healthcare stocks that Buffett owns, which you may also want to consider buying and holding for the long run.</p>\n<h2>1. Johnson &amp; Johnson</h2>\n<p>The first pharma stock within Berkshire's portfolio to contemplate purchasing is <b>Johnson &amp; Johnson</b> (NYSE:JNJ). While the stock is one of Buffett's smallest holdings, valued at just under $55 million, this doesn't take away from its 59 consecutive years of dividend increases that make the stock a Dividend King.</p>\n<p>J&amp;J will be spinning off its slower-growing and less profitable consumer health segment in the next 18 to 24 months, which should allow the company to focus on its faster-growing, more profitable pharmaceutical segment.</p>\n<p>J&amp;J has a strong existing drug portfolio, which should be able to make up for the upcoming 2025 to 2026 patent expirations for its top-selling drug known, Stelara. Year to date, the immunology drug made up just 9.9% of J&amp;J's $69 billion in net sales.</p>\n<p>These drugs include the immunology blockbuster Tremfya, which received its first of three U.S. Food and Drug Administration (FDA) approvals to date in July 2017. Another drug that was recently approved by the FDA was the oncology blockbuster called Darzalex, which received its first of nine FDA approvals to date in November 2015. These two drugs have grown their year-to-date revenue at high-40% clips year over year and should remain under patent most of this decade.</p>\n<p>J&amp;J's enviable existing drug portfolio and its nearly four dozen indications in late-stage clinical trials explain why analysts anticipate that the stock will deliver 8% annual non-GAAP (adjusted) earnings per share (EPS) growth over the next five years.</p>\n<p>Income investors can scoop up J&amp;J's 2.5% dividend yield at a forward P/E ratio of just 16.2 times, which makes the steady healthcare stock a great buy for the long term.</p>\n<h2>2. Bristol Myers Squibb</h2>\n<p>Another Buffett stock that could be a great fit in your portfolio is <b>Bristol Myers Squibb</b> (NYSE:BMY). Berkshire's Bristol Myers Squibb stake totals nearly $1.4 billion, making it one of the largest healthcare holdings in Berkshire's portfolio.</p>\n<p>Bristol Myers Squibb's oncology blockbusters Revlimid and Opdivo and the anticoagulant blockbuster co-owned with <b>Pfizer</b> (NYSE:PFE) named Eliquis each face patent expirations later this decade. While looming patent expirations on three drugs that account for approximately two-thirds of your company's total revenue sounds frightening, this is nothing new; it's just the nature of Bristol Myers Squibb's industry.</p>\n<p>What matters most is that a company is proactive in developing and acquiring its next generation of blockbuster drugs to absorb key patent expirations. With more than 50 compounds in over 40 different disease areas currently in development at Bristol Myers Squibb, this is exactly what the company has been doing for years now.</p>\n<p>As a result, analysts are projecting that Bristol Myers Squibb will be able to generate 6% annual earnings growth through the next five years.</p>\n<p>Yield-hungry investors can buy Bristol Myers Squibb's market-crushing 3.5% yield at a ridiculously cheap forward P/E ratio of 7.9, which is what makes the stock a buy for those looking to hedge against inflation.</p>\n<h2>3. AbbVie</h2>\n<p>Finally, a Buffett stock that'd also be a good fit for income investors is <b>AbbVie</b> (NYSE:ABBV). Berkshire currently holds about $1.9 billion worth of AbbVie stock.</p>\n<p>It's well known at this point that the biopharmaceutical's top-selling drug in the world, Humira, will be facing intense biosimilar competition in the U.S. beginning in 2023. Even though the immunology drug's U.S. sales made up 31% of AbbVie's $41.24 billion total year-to-date sales, the company's pipeline should be able to stabilize and grow its net revenue beyond 2023.</p>\n<p>AbbVie has 54 compounds in various stages of clinical trials, which is why analysts are forecasting that the stock will grow its adjusted EPS 4.5% annually in the next five years.</p>\n<p>AbbVie's massive 4.4% dividend yield can be picked up at a forward P/E ratio of only 9.3.&nbsp;This is an attractive valuation for a stock with the ability to fight off inflation with healthy dividend hikes.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Best Buffett Stocks to Buy for the Long Haul</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Best Buffett Stocks to Buy for the Long Haul\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-25 10:10 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/12/24/3-best-buffett-stocks-to-buy-for-the-long-haul/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Since Warren Buffett took full control of Berkshire Hathaway in 1965, it became a diversified holding company with investments in publicly traded companies totaling nearly $345 billion at the time of ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/24/3-best-buffett-stocks-to-buy-for-the-long-haul/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生","BMY":"施贵宝","ABBV":"艾伯维公司"},"source_url":"https://www.fool.com/investing/2021/12/24/3-best-buffett-stocks-to-buy-for-the-long-haul/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2193917872","content_text":"Since Warren Buffett took full control of Berkshire Hathaway in 1965, it became a diversified holding company with investments in publicly traded companies totaling nearly $345 billion at the time of writing.\nThe Oracle of Omaha's reputation of buying the highest quality businesses means that many individual investors could also benefit from adding these stocks to their portfolios. Here are three healthcare stocks that Buffett owns, which you may also want to consider buying and holding for the long run.\n1. Johnson & Johnson\nThe first pharma stock within Berkshire's portfolio to contemplate purchasing is Johnson & Johnson (NYSE:JNJ). While the stock is one of Buffett's smallest holdings, valued at just under $55 million, this doesn't take away from its 59 consecutive years of dividend increases that make the stock a Dividend King.\nJ&J will be spinning off its slower-growing and less profitable consumer health segment in the next 18 to 24 months, which should allow the company to focus on its faster-growing, more profitable pharmaceutical segment.\nJ&J has a strong existing drug portfolio, which should be able to make up for the upcoming 2025 to 2026 patent expirations for its top-selling drug known, Stelara. Year to date, the immunology drug made up just 9.9% of J&J's $69 billion in net sales.\nThese drugs include the immunology blockbuster Tremfya, which received its first of three U.S. Food and Drug Administration (FDA) approvals to date in July 2017. Another drug that was recently approved by the FDA was the oncology blockbuster called Darzalex, which received its first of nine FDA approvals to date in November 2015. These two drugs have grown their year-to-date revenue at high-40% clips year over year and should remain under patent most of this decade.\nJ&J's enviable existing drug portfolio and its nearly four dozen indications in late-stage clinical trials explain why analysts anticipate that the stock will deliver 8% annual non-GAAP (adjusted) earnings per share (EPS) growth over the next five years.\nIncome investors can scoop up J&J's 2.5% dividend yield at a forward P/E ratio of just 16.2 times, which makes the steady healthcare stock a great buy for the long term.\n2. Bristol Myers Squibb\nAnother Buffett stock that could be a great fit in your portfolio is Bristol Myers Squibb (NYSE:BMY). Berkshire's Bristol Myers Squibb stake totals nearly $1.4 billion, making it one of the largest healthcare holdings in Berkshire's portfolio.\nBristol Myers Squibb's oncology blockbusters Revlimid and Opdivo and the anticoagulant blockbuster co-owned with Pfizer (NYSE:PFE) named Eliquis each face patent expirations later this decade. While looming patent expirations on three drugs that account for approximately two-thirds of your company's total revenue sounds frightening, this is nothing new; it's just the nature of Bristol Myers Squibb's industry.\nWhat matters most is that a company is proactive in developing and acquiring its next generation of blockbuster drugs to absorb key patent expirations. With more than 50 compounds in over 40 different disease areas currently in development at Bristol Myers Squibb, this is exactly what the company has been doing for years now.\nAs a result, analysts are projecting that Bristol Myers Squibb will be able to generate 6% annual earnings growth through the next five years.\nYield-hungry investors can buy Bristol Myers Squibb's market-crushing 3.5% yield at a ridiculously cheap forward P/E ratio of 7.9, which is what makes the stock a buy for those looking to hedge against inflation.\n3. AbbVie\nFinally, a Buffett stock that'd also be a good fit for income investors is AbbVie (NYSE:ABBV). Berkshire currently holds about $1.9 billion worth of AbbVie stock.\nIt's well known at this point that the biopharmaceutical's top-selling drug in the world, Humira, will be facing intense biosimilar competition in the U.S. beginning in 2023. Even though the immunology drug's U.S. sales made up 31% of AbbVie's $41.24 billion total year-to-date sales, the company's pipeline should be able to stabilize and grow its net revenue beyond 2023.\nAbbVie has 54 compounds in various stages of clinical trials, which is why analysts are forecasting that the stock will grow its adjusted EPS 4.5% annually in the next five years.\nAbbVie's massive 4.4% dividend yield can be picked up at a forward P/E ratio of only 9.3. This is an attractive valuation for a stock with the ability to fight off inflation with healthy dividend hikes.","news_type":1},"isVote":1,"tweetType":1,"viewCount":312,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"defaultTab":"posts","isTTM":true}